临床试验/NCT00801866

NCT00801866撤回4 期

Prevention of Post-photocoagulation Macular Edema by Intravitreal Bevacizumab.

Asociación para Evitar la Ceguera en México1 个研究点分布在 1 个国家开始时间: 2008年12月最近更新: 2024年5月30日

适应症

干预措施

试验速览

阶段: 4 期
状态: 撤回
发起方
试验地点: 1
主要终点: Best Corrected Visual Acuity

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision

研究设计

研究类型: Interventional
主要目的: Treatment

入排标准

年龄范围: 15 Years 至 80 Years（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients with Proliferative retinopathy or severe non-proliferative retinopathy
•BCVA of 20/63 or better (56 ETDRS letters
•No history of Macular Edema
•Central Retinal Thickness of 250mics or more

排除标准

•Previous treatment.
•Other ophthalmic diseases. history of Nephropathy, heart diseases and pregnancy
•Media opacities

研究组 & 干预措施

Group 1

Experimental

Panretinal Photocoagulation + Bevacizumab

干预措施: Bevacizumab (Drug)

Group 2

Experimental

Panretinal Photocoagulation

干预措施: Panretinal Photocoagulation (Procedure)

结局指标

主要结局

Best Corrected Visual Acuity

次要结局

Central Retinal Thickness.

研究者

发起方

Asociación para Evitar la Ceguera en México

申办方类型

Other

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

撤回

3 期

Bevacizumab and Retinal Vascular OcclusionsEdema MacularVascular Occlusion

NCT00347711Asociación para Evitar la Ceguera en México

撤回

2 期

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyDiabetic Retinopathy

NCT00347698Asociación para Evitar la Ceguera en México

已完成

4 期

Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyDiabetic Traction Retinal DetachmentVitreous Hemorrhage

NCT01854593Nihon University69

已完成

1 期

Preoperative Bevacizumab for Vitreous HemorrhageVitreous HemorrhageDiabetic Retinopathy

NCT00596297University of Sao Paulo16

招募中

4 期

Efficacy of bevacizumab by intravitreal route in choroidal neovascular membrane of eye.

CTRI/2016/09/007288Govt medical college and sir takhtsinhji hospital bhavnagr30